-
Beijing Jialin Pharmaceuticals, is about to change owners
Time of Update: 2021-01-07
mentioned Jialin Pharmaceuticals, as a wholly-owned subsidiary of De-Exhibition Health, for many years in the adjustment / blood lipid-lowering drug market ranked as the leading position of domestic drugs, the main product "Al" (common name: Atovastatin calcium tablets) is the first product of the variety through a consistent evaluation.
-
Mindray announced: substitution of vice chairman and general manager
Time of Update: 2021-01-07
at present, the areas laid out by Murray are essential to enhance the ability of a general hospital medical services, so even under the premise of hospital control fees will not reduce equipment procurement, but will increase the procurement of cost-effective domestic products.
-
Tianma industrial products new strategy release media conference
Time of Update: 2021-01-02
On December 18, 2020, Tianma held an industrial roadshow in Shenzhen on the theme of "Together for a Win-Win", and held a media conference at the same time, emphasizing adherence to the "1 plus 1 plus
-
To Ling brand even won the 2020 Chinese medicine drink tablet brand list
Time of Update: 2021-01-02
In 2013, Yiling Pharmaceuticals established a planting base and processing base for the natural environment of the Tao real estate area of Taihangshan Mountain in Hebei Province, with the base as the center, relying on the advantages of industry, technology and so on, and constructed the industrial model of "company and base and farmer", from the cultivation, harvesting, processing and other aspects of the whole supervision of medicinal herbs, effectively ensuring the quality of medicinal herbs from the source.
-
Taiwan pharmaceutical factory from the 20th fire Taiwan media: estimated to be 21 can be completely extinguished
Time of Update: 2021-01-02
Medicine Network December 21st, had supplied the island's anti-epidemic raw materials, Taoyuan Xufu Pharmaceutical Factory on the 20th alarm fire, causing concern on the island.
-
The acquisition of a drug factory in Bayer, Germany, by a Chinese company will be used in the production of the new crown vaccine
Time of Update: 2021-01-02
completed its acquisition of Bayer's biologics plant (DP7) in Leverkusen, Germany, in April.
-
Confirmation: Medtron executive leaves
Time of Update: 2021-01-02
reported that Salmon joined Medtron in 2004 and has held senior management positions in the cardiovascular field for 15 years, including leading the coronary artery and renal neurology, excrement, cardiac surgery and heart structure business, before being appointed leader of Medtron Diabetes and a member of Medtron's Executive Committee in 2019.
-
Pryte Pharmaceuticals isopropyl tobly bromide inhalation aerosol imitation class 4 listing application was accepted
Time of Update: 2021-01-02
according to meters of intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal isopropyl bromide inhaler sales exceeded 1 billion for the first time; brand structure, Grigg Ingham has the largest market share, accounting for more than 90%.
-
Sichuan pharmaceutical companies won more than 10 billion anti-thrombosis drugs!
Time of Update: 2021-01-01
source: MED2.0 China Drug Review Database Hydrochlorocarpide tablets have Sanofi, Xinlitai, Lepu Pharmaceuticals, Stone Pharmaceuticals, Eoi Pharmaceuticals and more than 10 other production enterprises, of which Sanofi has the largest market share, up to 46.74 percent.
-
Donghuayuan medical Chinese medicine powder machine: fried soup to make powder, so that Chinese medicine services more convenient
Time of Update: 2021-01-01
chinese medicine powder machine developed by Donghuayuan Medical, which retains the changes in the cooking process, adopts the "microwave and vacuum" technology, and will dry the soup directly.
-
Hengrui Pharmaceutical 4 products are included in the health insurance
Time of Update: 2021-01-01
On the evening of December 29th, Jiangsu Hengrui Pharmaceutical Co., Ltd. (here called Hengrui Pharmaceuticals) announced that the company's products were successfully negotiated with Karelli pearl mo
-
Official Xuan! Important personnel changes at Vigo
Time of Update: 2020-12-23
Mr. Chan is an Executive Director of Vigo Group Corporation and Weihai Waigao International Medical Investment Holdings Limited and, except as disclosed above, has not held any other directorship in the Group or any other public company whose securities are listed on any securities market in Hong Kong or overseas in the past three years, except as disclosed above.
-
Another subsidiary of The Micro-Invascope Medical Spin-Off has recently been listed three times
Time of Update: 2020-12-23
The market is about to explode it is understood that surgical robots are a kind of medical robots that can be used for surgical imaging guidance and minimally invasive surgery, on the one hand, surgical robots can overcome traditional surgical accuracy, long time, easy fatigue, lack of 3D medical image navigation and other technical defects; according to China Industry Information Network, the most widely used surgical robot in the world is the Da Vinci surgical machine man produced by IntuitiveSurgical.
-
Huiyu pharmaceutical imitation 4 types of yew alcohol injection into the administrative approval stage
Time of Update: 2020-12-23
Yew alcohol product evaluation enterprise source: Mi net consistency evaluation database is currently listed in the domestic market yew alcohol products include yew alcohol injection, injection of yew alcohol lipids and injection of yew alcohol (albumin binding type).
-
Novart's sales team is about to change sales positions
Time of Update: 2020-12-13
Novarma said in an e-mail that the merger of the new Cardiovascular, Kidney and Metabolic Divisions is one of the strategic initiatives taken by the company to integrate resources, promote innovation, strengthen the grass roots and contribute to Novarma Pharmaceuticals' sustainable development in China, and the newly established Division will also be directly connected to the CRM Division, the headquarters of one of Novarce Pharmaceuticals' five global business units.
-
Qilu's new entry! Yuandong, Howson, Beit attacked $1.5 billion anti-thrombosis varieties
Time of Update: 2020-12-13
Figure 1: The registration of Dabiga group ester capsules by Qilu Pharmaceuticals Source: CDE Official Chart 2: Global sales of Dabiga esters in Bringelingham (in millions of dollars) Source: Mienet Multinational Listed Companies Sales Database Group esters belong to β-Alanine-type clotting enzyme inhibitors, are prebiotic drugs of the Dabiga group, used to prevent stroke and systemic embolism in patients with non-valve atrial fibrillation, treat acute deep vein thyroid formation or pulmonary embolism, and prevent recurrence.
-
Qilu is going to grab the first imitation again! The three major eye drops in the trial hit the 10 billion market
Time of Update: 2020-12-13
This product is suitable for reducing the open angle glazing and high eye pressure patients in the eye pressure, the current domestic market only the United States Aer Jian approved imports, Qilu Pharmaceuticals for the product's first declared imitation listed pharmaceutical companies.
-
Lepp's big news was announced
Time of Update: 2020-12-13
According to China Pharmaceutical Network data, China's in-body diagnostic production and research and development enterprises more than 1,000, in 2018 domestic enterprises revenue scale is less than 5 billion yuan, and in-body diagnostic multinational Danaher company in 2018 to achieve operating income of nearly 20 billion U.S. dollars.
-
Evaporation of nearly 10 billion in a single day! Watson creature with HPV vaccine 'under siege'
Time of Update: 2020-12-12
This strong market reaction was sparked on December 4th by Watson Bio's announcement that it would transfer 32.60 per cent of Shanghai Zerun for 1.14 billion yuan, while giving up the preferred recognition of the capital increase, after which the listed company will hold 28.5 per cent of Shanghai Zerun, which will no longer be its controlling subsidiary.
-
BlueFan Medical intends to invest an additional 2.45 billion plus yards of protective gloves during the year four expansion of production is expected to increase the built capacity by more than three times
Time of Update: 2020-12-12
reporter noted that this is the fourth time in the year that BlueFan Medical disclosed the expansion plan, if the construction of this expansion project is completed, BlueFan Medical's annual production capacity of health protection gloves will reach 80 billion units, an increase of 3.4 times over the end of 2019.
